Rametrix Technologies Inc: Molecular Urinalysis as a Disease and Drug Screening Tool
Dr. John Robertson, President and CEO of Rametrix Technologies, will discuss how the company’s Raman spectroscopy-based platform has the potential to improve medical care and outcomes. He will explain how the company designs and engineers around its spectroscopy platform which can be used for drug checking at Points-of-Care in hospitals and clinics.